TOI
The Oncology Institute, Inc. (NASDAQ)
Healthcare — Medical Care Facilities
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Price History
Fundamentals
| Market Cap | $552.91M |
| P/E Ratio (TTM) | - |
| Forward P/E | -34.56 |
| EPS (TTM) | $-0.35 |
| Dividend Yield | - |
| Profit Margin | -7.97% |
| Revenue Growth | 41.20% |
| ROE | - |
| Debt/Equity | - |
| Recommendation | Strong Buy 1.3 |
| Analyst Target | $7.75 |
| Analysts | 4 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 60.4 |
| Beta | 0.41 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $5.82 |
| 52-Week Low | $2.32 |
| 50-Day Avg | $4.47 |
| 200-Day Avg | $3.65 |
| Avg Volume | $1.89M |
| Volume | $1.58M |
Performance Analysis
BULLISHTOI shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Jul 02, 2026 13:34 UTC
Back to Screener Export Report